Rigel Pharmaceuticals
RIGL
RIGL
95 hedge funds and large institutions have $300M invested in Rigel Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 12 closing their positions.
Holders
95
Holders Change
+1
Holders Change %
+1.06%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
30
Reduced
33
Closed
12
Calls
$1.1M
Puts
$531K
Net Calls
+$572K
Net Calls Change
+$2.96M
Top Buyers
| 1 |
PAI
1
Palo Alto Investors
Palo Alto,
California
|
$22.6M |
| 2 |
2
Morgan Stanley
New York
|
$4.94M |
| 3 |
3
Millennium Management
New York
|
$10.3M |
| 4 |
BC
4
Broadfin Capital
New York
|
$12.8M |
| 5 |
BBA
5
Baker Bros. Advisors
New York
|
$1.79M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WB
101
WesBanco Bank
Wheeling,
West Virginia
| – | – | -4,000 | Closed |
|
|
U
102
UBS
Zurich,
Switzerland
| – | – | -2,213 | Closed |
|
|
BJ
103
BlackRock Japan
Tokyo,
Japan
| – | – | -1,722 | Closed |
|
104
Nomura Holdings
Tokyo,
Japan
| – | – | -1,162 | Closed |
|
|
WAM
105
Wolverine Asset Management
Chicago,
Illinois
| – | – | -270 | Closed |
|
|
LWCFA
106
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
| $0 | 3 | – | – |
|
|
CGT
107
Capital Guardian Trust
Los Angeles,
California
| $0 | 5 | – | – |
|